Increasing evidence has suggested that galectin-1 is elevated in cancer tissues and a high expression level of galectin-1 is associated with poor OS and DFS in different cancer types, particularly in digestive cancers [19, 52]. This evidence concerns the gene LGALS1 and cancer.